Ticker Details
Co-Diagnostics, Inc. Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
IPO Date:	July 12, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$5.19M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.45%
Avg Daily Range (30 D):	$0.21 | 8.51%
Avg Daily Range (90 D):	$0.17 | 6.40%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	1.66M
Avg Daily Volume (90 D):	.61M

Trade Size
Avg Trade Size (Sh.):	29
Avg Trade Size (Sh.) (30 D):	104
Avg Trade Size (Sh.) (90 D):	87

Institutional Trades
Total Institutional Trades:	366
Avg Institutional Trade:	$1.31M
Avg Institutional Trade (30 D):	$1.48M
Avg Institutional Trade (90 D):	$1.48M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.97M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.67K

News

Mar 31, 2026 @ 8:01 PM Co-Diagnostics Reports Full Year 2025 Financial Re... Source: Prnewswire

Mar 25, 2026 @ 12:00 PM Co-Diagnostics Ships Diagnostic Materials to India... Source: Prnewswire

Dec 30, 2025 @ 2:00 PM Co-Diagnostics Announces Reverse Stock Split Source: Prnewswire

Dec 8, 2025 @ 5:36 PM Co-Diagnostics JV, CoSara, to Participate at VIROC... Source: Prnewswire

Oct 22, 2025 @ 12:30 PM Co-Diagnostics Executive Leadership Team to Attend... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-35.25	$-34.63	$-35.25
Diluted EPS	$-35.25	$-34.63	$-35.25
Revenue	$.62M	$.26M	$.62M
Gross Profit	$.4M	$.12M	$.4M
Net Income / Loss	$-46.9M	$-25.75M	$-46.9M
Operating Income / Loss	$-50.17M	$-26.54M	$-50.17M
Cost of Revenue	$.22M	$.14M	$.22M
Net Cash Flow	$8.95M	$8.95M	$8.95M
PE Ratio

Splits
Jan 02, 2026	1:30